| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 36,808 | 37,871 | 37,281 | 37,659 | | Cost of Revenue | 24,236 | 24,404 | 24,819 | 25,626 | | | Gross Profit | 12,572 | 13,467 | 12,462 | 12,033 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,682 | 11,389 | 10,717 | 10,551 | | Non Recurring |
-
| 5,736 |
-
| (82) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,890 | (3,658) | 1,745 | 1,564 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 105 | 17 | 13 | 253 | | Earnings Before Interest And Taxes | 1,995 | (3,641) | 1,758 | 1,817 | | Interest Expense | 3,840 | 3,753 | 3,608 | 3,759 | | Income Before Tax | (1,845) | (7,394) | (1,850) | (1,942) | | Income Tax Expense | 539 | 397 | 499 | 499 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,384) | (7,791) | (2,349) | (2,441) | | | Non-recurring Events | | Discontinued Operations |
-
| 114 | (47) | (50) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,384) | (7,677) | (2,396) | (2,491) | | Preferred Stock And Other Adjustments | (899) | (874) | (849) | (825) | | | Net Income Applicable To Common Shares | ($3,283) | ($8,551) | ($3,245) | ($3,316) |
|
0.56% Nasdaq 
0.0895 
Income Statement
